149 related articles for article (PubMed ID: 35697066)
21. Population-Based Long-term Cardiac-Specific Mortality Among Patients With Major Gastrointestinal Cancers.
Ramai D; Heaton J; Ghidini M; Chandan S; Barakat M; Dhindsa B; Dhaliwal A; Facciorusso A
JAMA Netw Open; 2021 Jun; 4(6):e2112049. PubMed ID: 34137831
[TBL] [Abstract][Full Text] [Related]
22. Chemoprevention trials of GI cancers in Asia.
Li JW; Tan MT; Ang TL; Teo EK
Best Pract Res Clin Gastroenterol; 2015 Dec; 29(6):967-78. PubMed ID: 26651257
[TBL] [Abstract][Full Text] [Related]
23. Impact of detection bias on the risk of gastrointestinal cancer and its subsites in type 2 diabetes mellitus.
de Jong RGPJ; Burden AM; de Kort S; van Herk-Sukel MPP; Vissers PAJ; Janssen PKC; Haak HR; Masclee AAM; de Vries F; Janssen-Heijnen MLG
Eur J Cancer; 2017 Jul; 79():61-71. PubMed ID: 28463757
[TBL] [Abstract][Full Text] [Related]
24. Molecular Detection of Gastrointestinal Neoplasia: Innovations in Early Detection and Screening.
Anderson BW; Ahlquist DA
Gastroenterol Clin North Am; 2016 Sep; 45(3):529-42. PubMed ID: 27546847
[TBL] [Abstract][Full Text] [Related]
25. Linking type 2 diabetes and gynecological cancer: an introductory overview.
Anastasi E; Filardi T; Tartaglione S; Lenzi A; Angeloni A; Morano S
Clin Chem Lab Med; 2018 Aug; 56(9):1413-1425. PubMed ID: 29427549
[TBL] [Abstract][Full Text] [Related]
26. Diabetes mellitus as a risk factor for gastrointestinal cancers among postmenopausal women.
Luo J; Chlebowski R; Liu S; McGlynn KA; Parekh N; White DL; Margolis KL
Cancer Causes Control; 2013 Mar; 24(3):577-85. PubMed ID: 22622863
[TBL] [Abstract][Full Text] [Related]
27. Clinical significance of glycemic parameters on venous thromboembolism risk prediction in gastrointestinal cancer.
Guadagni F; Riondino S; Formica V; Del Monte G; Morelli AM; Lucchetti J; Spila A; D'Alessandro R; Della-Morte D; Ferroni P; Roselli M
World J Gastroenterol; 2017 Jul; 23(28):5187-5195. PubMed ID: 28811713
[TBL] [Abstract][Full Text] [Related]
28. Endoscopy for upper GI cancer screening in the general population: a cost-utility analysis.
Gupta N; Bansal A; Wani SB; Gaddam S; Rastogi A; Sharma P
Gastrointest Endosc; 2011 Sep; 74(3):610-624.e2. PubMed ID: 21741639
[TBL] [Abstract][Full Text] [Related]
29. Cadherin-17 is a useful diagnostic marker for adenocarcinomas of the digestive system.
Su MC; Yuan RH; Lin CY; Jeng YM
Mod Pathol; 2008 Nov; 21(11):1379-86. PubMed ID: 18552820
[TBL] [Abstract][Full Text] [Related]
30. [A new transition of the screening, early diagnosis and early treatment project of the upper gastrointestinal cancer: opportunistic screening].
Wang GQ; Wei WW
Zhonghua Yu Fang Yi Xue Za Zhi; 2019 Nov; 53(11):1084-1087. PubMed ID: 31683391
[TBL] [Abstract][Full Text] [Related]
31. Hepatocellular carcinoma as a leading cause of cancer-related deaths in Japanese type 2 diabetes mellitus patients.
Shima T; Uto H; Ueki K; Kohgo Y; Yasui K; Nakamura N; Nakatou T; Takamura T; Kawata S; Notsumata K; Sakai K; Tateishi R; Okanoue T
J Gastroenterol; 2019 Jan; 54(1):64-77. PubMed ID: 30006904
[TBL] [Abstract][Full Text] [Related]
32. Diabetes and Cancer: Cancer Should Be Screened in Routine Diabetes Assessment.
Suh S; Kim KW
Diabetes Metab J; 2019 Dec; 43(6):733-743. PubMed ID: 31902143
[TBL] [Abstract][Full Text] [Related]
33. Gastrointestinal tumor board: an evolving experience in Tehran Cancer Institute.
Haddad P; Mir MR; Jamali M; Abdirad A; Alikhasi A; Farhan F; Memari F; Sadighi S; Shahi F
Acta Med Iran; 2013 May; 51(4):270-3. PubMed ID: 23690109
[TBL] [Abstract][Full Text] [Related]
34. Association between diabetes and esophageal cancer, independent of obesity, in the United States Veterans Affairs population.
Dixon JL; Copeland LA; Zeber JE; MacCarthy AA; Reznik SI; Smythe WR; Rascoe PA
Dis Esophagus; 2016 Oct; 29(7):747-751. PubMed ID: 26455587
[TBL] [Abstract][Full Text] [Related]
35. Surveillance for gastrointestinal malignancies.
Tiwari AK; Laird-Fick HS; Wali RK; Roy HK
World J Gastroenterol; 2012 Sep; 18(33):4507-16. PubMed ID: 22969223
[TBL] [Abstract][Full Text] [Related]
36. [Role of CDX2 immunostaining in diagnosis of gastrointestinal adenocarcinoma].
Wang C; Zhou XG
Zhonghua Bing Li Xue Za Zhi; 2006 Apr; 35(4):228-31. PubMed ID: 16776981
[TBL] [Abstract][Full Text] [Related]
37. A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors.
Lu L; Mullins CS; Schafmayer C; Zeißig S; Linnebacher M
Cancer Commun (Lond); 2021 Nov; 41(11):1137-1151. PubMed ID: 34563100
[TBL] [Abstract][Full Text] [Related]
38. [Malignant tumors of the gastrointestinal tract and their early diagnosis].
Riemann JF
Fortschr Med; 1978 Mar; 96(12):625-30. PubMed ID: 147228
[TBL] [Abstract][Full Text] [Related]
39. Recent Advances of Functional Proteomics in Gastrointestinal Cancers- a Path towards the Identification of Candidate Diagnostic, Prognostic, and Therapeutic Molecular Biomarkers.
Abyadeh M; Meyfour A; Gupta V; Zabet Moghaddam M; Fitzhenry MJ; Shahbazian S; Hosseini Salekdeh G; Mirzaei M
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33198323
[TBL] [Abstract][Full Text] [Related]
40. Analysis of fecal DNA methylation to detect gastrointestinal neoplasia.
Nagasaka T; Tanaka N; Cullings HM; Sun DS; Sasamoto H; Uchida T; Koi M; Nishida N; Naomoto Y; Boland CR; Matsubara N; Goel A
J Natl Cancer Inst; 2009 Sep; 101(18):1244-58. PubMed ID: 19700653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
